Liver and Bile

Clin Gastroenterol Hepatol. 2024;22(8):1646–56.e2

Musto JA, Palmer G, Nemer M, Schell T, Waclawik G, Glover Q, Lucey MR, Osman F, Rice JP

Early liver transplant for alcohol-associated liver disease has excellent survival but higher rates of harmful alcohol use


Background and aims: Early liver transplantation (LT) for alcohol-associated liver disease (ALD) has increased worldwide. Short-term outcomes have been favorable, but data on longer-term outcomes are lacking.
Methods: Single-center retrospective study of primary LT recipients between 2010 and 2020, with follow-up through July 1, 2022. Survival analysis was performed using log rank, Cox models, and Kaplan-Meier method. Cox models were created to identify variables associated with mortality; logistic regression to identify variables associated with post-LT alcohol use.
Results: Of 708 patients who underwent LT, 110 (15.5%) had ALD and abstinence < 6 months prior to LT (early LT, ELT), 234 (33.1%) had ALD and alcohol abstinence > 6 months (standard LT, SLT), and 364 (51.4%) had non-ALD diagnoses. Median follow-up was 4.6 years (interquartile range, 2.6–7.3 years). ELT recipients were younger (p = 0.001) with median abstinence pre-LT of 61.5 days. On adjusted Cox model, post-LT survival was similar in ELT and SLT (hazard ratio [HR] = 1.31; p = 0.30) and superior to non-ALD (HR = 1.68; p = 0.04). Alcohol use (40.9% vs. 21.8%; p < 0.001) and harmful alcohol use (31.2% vs. 16.0%; p = 0.002) were more common in ELT recipients. Harmful alcohol use was associated with post-LT mortality on univariate (HR = 1.69; p = 0.03), but not multivariable regression (HR = 1.54; p = 0.10). Recurrence of decompensated ALD trended toward more common in ELT (9.1% vs. 4.4%; p = 0.09). Greater than 6 months pre-LT abstinence was associated with a decreased risk of harmful alcohol use (odds ratio [OR] = 0.42; p = 0.001), but not in a multivariable model (OR = 0.71; p = 0.33).

Conclusions: Patients who undergo early liver transplantation (LT) for alcohol-associated liver disease have similar or better survival than other diagnoses in the first 10 years after LT despite a higher incidence of post-LT alcohol use.

J.A. Musto, University of Wisconsin Medical Foundation, Madison, WI, USA, E-Mail: jamusto@medicine.wisc.edu

DOI:  10.1016/j.cgh.2024.04.025

Back to overview

this could be of interest:

Liver and Bile

A phase 2 randomized trial of survodutide in MASH and fibrosis

N Engl J Med. 2024;391(4):311–9

More articles on the topic